Abstract | PURPOSE: METHODS: GCC mRNA was quantified by RT-qPCR using formalin-fixed LN tissues from patients with untreated stage II colon cancer who were diagnosed from 1999-2006 with at least ten LNs examined and blinded to clinical outcomes. Lymph node ratio (LNR) is the number of GCC-positive nodes divided by total number of informative LNs. Risk categories of low (0-0.1) and high (>0.1) for LNR were chosen by significance using Cox regression models. The data were tested for association with time to recurrence. RESULTS: Twenty-nine patients (12%) had a disease recurrence or cancer death. The LNR significantly predicted higher recurrence risk for 84 patients (34.9%) classified as high risk (hazard ratio (HR), 2.38; P=0.02). The estimated 5-year recurrence rates were 10% and 27% for the low- and high-risk groups, respectively. After adjusting for age, T stage, number of nodes assessed, and MMR status, a significant association remained (HR, 2.61; P=0.02). In a subset of patients (n=181) with T3 tumor, ≥12 nodes examined and negative margins, a significant association between the GCC LNR and recurrence risk also was observed (HR, 5.06; P=0.003). CONCLUSIONS: Our preliminary results suggest that detection of GCC mRNA in LNs is associated with risk of disease recurrence in patients with untreated stage II colon cancer. A larger validation study is ongoing.
|
Authors | Daniel J Sargent, Murray B Resnick, Michael O Meyers, Atoussa Goldar-Najafi, Thomas Clancy, Sharlene Gill, Gary O Siemons, Qian Shi, Brian M Bot, Tsung-Teh Wu, Guillaume Beaudry, Jean-François Haince, Yves Fradet |
Journal | Annals of surgical oncology
(Ann Surg Oncol)
Vol. 18
Issue 12
Pg. 3261-70
(Nov 2011)
ISSN: 1534-4681 [Electronic] United States |
PMID | 21533822
(Publication Type: Journal Article)
|
Chemical References |
- RNA, Messenger
- Receptors, Peptide
- Guanylate Cyclase
- Receptors, Enterotoxin
- Receptors, Guanylate Cyclase-Coupled
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Colonic Neoplasms
(enzymology, genetics, pathology)
- Female
- Follow-Up Studies
- Guanylate Cyclase
(genetics)
- Humans
- Lymph Nodes
(pathology)
- Lymphatic Metastasis
- Male
- Middle Aged
- Neoplasm Recurrence, Local
(diagnosis, enzymology, genetics)
- Neoplasm Staging
- Prognosis
- Prospective Studies
- RNA, Messenger
(genetics)
- Receptors, Enterotoxin
- Receptors, Guanylate Cyclase-Coupled
(genetics)
- Receptors, Peptide
(genetics)
- Retrospective Studies
- Reverse Transcriptase Polymerase Chain Reaction
- Survival Rate
|